NDA participates in the 1st African Medicines Agency (AMA) Joint Review of an Ebola Clinical Trial Protocol
The National Drug Authority participated in the 1st African Medicines Agency (AMA) Joint Review of an Ebola Clinical Trial Protocol, a four-day workshop at Kampala Sheraton. Jointly organized by AMA, UNCST, and NDA with support from CEPI, the workshop brought together representatives from Ethiopian FDA, NAFDAC, Rwanda FDA, UNHRO, UVRI-REC, and other regulatory and research…
